Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.

ABSTRACT:

SUBMITTER: Liao W 

PROVIDER: S-EPMC12328289 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature